metformin has been researched along with masoprocol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Brignetti, D; Claypool, MD; Entes, LJ; Khandwala, A; Luo, J; Meszaros, K; Pinkett, JG; Reaven, GM; Reed, MJ | 1 |
Antebi, A; Astle, CM; Bogue, M; de Magalhães, JP; Denzel, MS; Fernandez, E; Flurkey, K; Hamilton, KL; Harrison, DE; Javors, MA; Lamming, DW; Martinez, PA; McCord, JM; Miller, BF; Miller, RA; Müller, M; Nadon, NL; Ndukum, J; Nelson, JF; Rainger, GE; Richardson, A; Sabatini, DM; Salmon, AB; Simpkins, JW; Steegenga, WT; Strong, R | 1 |
4 other study(ies) available for metformin and masoprocol
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
Topics: Adipocytes; Animals; Antioxidants; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Fats; Fatty Acids, Nonesterified; Feeding Behavior; Hypoglycemic Agents; Insulin; Male; Masoprocol; Metformin; Rats; Rats, Sprague-Dawley; Triglycerides | 1999 |
Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer.
Topics: Acarbose; alpha-Glucosidases; Animals; Antioxidants; Drugs, Chinese Herbal; Estradiol; Fish Oils; Glycoside Hydrolase Inhibitors; Hand Strength; Longevity; Male; Masoprocol; Metformin; Mice; NF-E2-Related Factor 2; Rotarod Performance Test; Sirolimus; Survival Analysis; Ursodeoxycholic Acid | 2016 |